Cleared Traditional

9Line (K211941) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211941 · Energetic Designs, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
218d
Days
Class 2
Risk

K211941 is an FDA 510(k) clearance for the 9Line. Classified as Cable, Transducer And Electrode, Patient, (including Connector) (product code DSA), Class II - Special Controls.

Submitted by Energetic Designs, Inc. (Broomfield, US). The FDA issued a Cleared decision on January 27, 2022 after a review of 218 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2900 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Energetic Designs, Inc. devices

Submission Details

510(k) Number K211941 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2021
Decision Date January 27, 2022
Days to Decision 218 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 125d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSA Cable, Transducer And Electrode, Patient, (including Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

FDA 510k Consultants, LLC
John F. Gillespy

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DSA Cable, Transducer And Electrode, Patient, (including Connector)

All 41
Devices cleared under the same product code (DSA) and FDA review panel - the closest regulatory comparables to K211941.
RFP-100A Connector Cable (Single Use)
K230571 · Baylis Medical Technologies, Inc. · May 2023
SpO2 Extension Cable
K222370 · Beijing Rongrui-Century Science & Technology Co., Ltd. · Apr 2023
Med-link Disposable ECG Cable and Leadwires
K220447 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Jun 2022
Multi-Link X2 ECG Cable and Leadwire System
K211294 · Vyaire Medical, Inc. · Aug 2021
Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables
K203556 · Medtronic, Inc. · Jul 2021
PCA-C1 series Patient Cable
K200722 · QT Medical, Inc. · Jun 2021